▶️ Watch the press conference by Commissioner @SKyriakidesEU on vaccine deliveries and on the export transparency scheme. #StrongerTogether https://t.co/iczvKiAiRm — European Commission 🇪🇺 (@EU_Commission) January 25, 2021 Last Friday, the company AstraZeneca surprisingly informed the Commission and the European Union Member States that it intends to supply considerably fewer doses in the coming weeks than […]
Read MoreThe University of Almeria, the first Andalusian university and the second in Spain to obtain certification from AENOR’s COVID-19
19, the first university in Andalusia and the second in Spain to achieve such a prestigious certification, demonstrating its total commitment to the protection of students, PAS and PDI. With great satisfaction the Management of the University of Almeria has received the notification coming from AENOR: it has been granted the Certification of Protocols in […]
Read MoreCommission concludes exploratory talks with Valneva to secure a new potential vaccine
The European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses. This finalisation […]
Read MoreTorrecárdenas: the only hospital in Andalusia participating in the FOCUS program
After a selection process, Torrecárdenas University Hospital will participate in the implementation of the FOCUS program. The FOCUS program has been underway since 2010 and it aims to provide early diagnosis of infections such as HIV and Hepatitis C in hospitals and health centers. This is possible thanks to the agreement between the Andalusian Health […]
Read MoreEMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by AstraZeneca and Oxford University. The assessment of the vaccine, known as COVID-19 Vaccine AstraZeneca, will proceed under an accelerated timeline. An opinion on the marketing authorisation could be issued by 29 January during the meeting of EMA’s scientific committee for human […]
Read MoreEuropean Commission authorises second safe and effective vaccine against COVID-19
The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is endorsed […]
Read MoreEU and AU sign partnership to scale up preparedness for health emergencies
The European Centre for Disease Prevention and Control (ECDC) and the Africa Centres for Disease Control and Prevention (Africa CDC) is today launching a new four-year partnership initiative in order to enhance mutual engagement and contribute to durably strengthening Africa CDC capacities in preparedness and response to health threats. Entitled ‘EU for health security in […]
Read MoreEuropean Commission authorises first safe and effective vaccine against COVID-19
The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency […]
Read MoreThe Council and the European Parliament agree provisionally on the EU4Health programme for 2021-2027
The German presidency of the Council and the European Parliament reached a provisional deal on the EU4Health programme for 2021-2027. With a budget of EUR 5.1 billion, the new reinforced programme provides a strong basis for Union action in the health field based on lessons learned during the COVID-19 pandemic. It comes at a time […]
Read More